C9069 – Injection, belantamab mafodontin-blmf, 0.5 mg

Long description

Injection, belantamab mafodontin-blmf, 0.5 mg

Short description

Belantamab mafodontin-blmf

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1D Chemotherapy

Cross reference

J9037

Added

January 1, 2021

Last change

April 1, 2021 – No change

Termination date

March 31, 2021

Nearby C codes

• C9061 – Injection, teprotumumab-trbw, 10 mg
• C9062 – Injection, daratumumab 10 mg and hyaluronidase-fihj
• C9063 – Injection, eptinezumab-jjmr, 1 mg
• C9064 – Mitomycin pyelocalyceal instillation, 1 mg
• C9065 – Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
• C9066 – Injection, sacituzumab govitecan-hziy, 2.5 mg
• C9067 – Gallium ga-68, dotatoc, diagnostic, 0.01 mci
• C9068 – Copper cu-64, dotatate, diagnostic, 1 millicurie
• C9070 – Injection, tafasitamab-cxix, 2 mg
• C9071 – Injection, viltolarsen, 10 mg
• C9072 – Injection, immune globulin (asceniv), 500 mg
• C9073 – Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9074 – Injection, lumasiran, 0.5 mg
• C9075 – Injection, casimersen, 10 mg
• C9076 – Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9077 – Injection, cabotegravir and rilpivirine, 2mg/3mg